Results 111 to 120 of about 6,983 (163)

A Multiplexed, Target-Based Phenotypic Screening Platform Using CRISPR Interference in <i>Mycobacterium abscessus</i>. [PDF]

ACS Infect Dis
Neo DM, Ben-Zion I, Bagnall J, Solomon MY, Bond AN, Gath E, Zhang S, Shoresh N, Gomez J, Hung DT.   +9 more
europepmc   +1 more source

Community-based intervention to address antibiotic resistance: protocol for an embedded mixed-methods intervention trial. [PDF]

BMJ Public Health
Jha SS, Lahiri A, Dobe M, Mukherjee B, Raj A, Banik A, Taklikar C.   +6 more
europepmc   +1 more source

Zinc pyrithione impairs iron-sulfur cluster biogenesis in Mycobacterium tuberculosis. [PDF]

BMC Microbiol
Wang L, Wang X, Xu L, Wang B, Ji D, Ye Y, Lu Y.   +6 more
europepmc   +1 more source

Case Report: Pulmonary color Doppler ultrasonography features of congenital tuberculosis in a preterm infant. [PDF]

Front Pediatr
Zhou D, Guo W, Ma D, Zhang Y.
europepmc   +1 more source

Tuberculosis-triggered cytokine storm with hemophagocytic lymphohistiocytosis and tuberculous spondylitis in an apparently immunocompetent host: a case report and literature review. [PDF]

Front Immunol
Zhu L, Lu J, Chen Y.
europepmc   +1 more source

Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill the gap for fluoroquinolone testing? [PDF]

J Clin Microbiol
Armstrong DT, Baird ECE, Pretty L, D'Agostino K, Schwartz M, Campódonico VL, Parrish N.   +6 more
europepmc   +1 more source

Flavonoids: Potential Novel Inhibitors of Mycobacterium tuberculosis. [PDF]

Infect Disord Drug Targets
Kisimba K, Kasumbwe K, Odun-Ayo F, Faya M.   +3 more
europepmc   +1 more source

Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system. [PDF]

J Antimicrob Chemother
Raaijmakers J, Aarnoutse R, Te Brake L, Stemkens R, Wertheim H, Hoefsloot W, van Ingen J.   +6 more
europepmc   +1 more source

Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives. [PDF]

RSC Adv
Rakshit G, Chakraborty S, Bhakta S, Jayaprakash V.   +3 more
europepmc   +1 more source

Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance. [PDF]

Pharmaceutics
Sharma A, Sharma V, Sharma S, Sharma S, Sharma M, Sivanesan I.   +5 more
europepmc   +1 more source